Mic-1


Also found in: Acronyms, Wikipedia.

Mic-1

Microprogramming language, used in Andrew Tanenbaum's book.

See Mac-1.

[Structured Computer Organization, A.S. Tanenbaum, 3rd ed, P-H 1989, Sect 4.4, 4.5].
References in periodicals archive ?
Serum levels of MIC-1 were significantly increased in women ( P = 0.001) or elderly patients aged 60 years and older ( P < 0.001).
Of those patients who died during the follow-up period, serum MIC-1 levels before treatment (1859 [+ or -] 737 pg/ml) were considerably greater than those of the survived patients (1428 [+ or -] 852 pg/ml; P = 0.042) [Table 1].
Patients were grouped using a serum MIC-1 level of 1465 pg/ml as a criterion [Table 2].
Kaplan-Meier survival curve showed that the 3-year survival rate of patients with serum MIC-1 ≥1465 pg/ml was 77.6%, which was significantly lower than that of patients with serum MIC-1 <1465 pg/ml (94.8%) [Figure 4].
Univariate Cox survival analysis indicated that the high mortality risk was significantly associated with high serum levels of MIC-1 ( HR : 4.56, 95% CI : 1.62–12.79, P = 0.004).
In this study, a double antibody sandwich serum ELISA serum MIC-1 test kit was used to conduct a serologic study on early-stage NSCLC patients, BPD patients, and healthy controls.
Although low-dose computed tomography (LDCT) screening is used to screen out patients with early-stage cancer and to reduce the mortality of lung cancer, false-positive diagnoses still exist.[sup][21],[22] Therefore, it is possible that a specific serum marker, such as MIC-1, may assist LDCT in improving early detection rates of NSCLC.
Studies on the serum levels of MIC-1 in patients with early-stage NSCLC showed that the serum MIC-1 levels of females and elderly patients aged 60 years or older were higher than those of males, and young or middle-aged patients, suggesting that MIC-1 levels may be related to age and gender.
Further studies on the prognosis of patients indicated that serum MIC-1 level can be used as a biomarker to determine the prognosis of patients with early-stage NSCLC.
The time of death following surgery in groups with different serum MIC-1 levels indicated that a postoperative follow-up within 18 months should be done in patients with low serum MIC-1 levels while continuous regular follow-ups are needed for patients with high serum MIC-1 levels.